The Food Standards Agency (FSA) has announced some updates in their approach to the consumer CBD industry. The key developments are as follows: The FSA continue to maintain that 10mg per day is the Acceptable Daily Intake (ADI), with some exceptions. The evidence behind this position remains unpublished. The FSA have established a ‘safe upper […]
Read More
In this month’s episode, Luke speaks to Nicole Farah, Founder and MD of Americana Communications. Nicole explores the role of effective PR in shaping the narrative surrounding cannabis and influencing legislation. Throughout she unpacks the differences that define discourse and policy on both sides of the Atlantic. The podcast can be listened to now via […]
Read More
CIC CEO Mike Morgan-Giles was a guest on the Institute of Economic Affairs (IEA) podcast this week, discussing cannabis policy and much more with host Reem Ibrahim. Mike discussed the CIC’s position on cannabis matters, as well as some wider thoughts on policy in general. Watch/listen now:
Read More
Following publication of the letter from Home Office Minister Rt Hon Dame Diana Johnson MP to the ACMD this week, CIC CEO Mike Morgan-Giles commented: “The Cannabis Industry Council welcomes the Government asking the ACMD to review the state of play in the medical cannabis industry. “However, medical cannabis prescriptions in the UK lag far […]
Read More
Industry leaders Frances Crewdson and Tom Gray have been elected as the new Co-Chairs of the Cannabis Industry Council (CIC), taking on the baton from Dr. Callie Seaman and Jamie Bartley. Frances has been Chair of the CIC Standards Working Group since 2024, as well as being a Director of CannDo Consulting. Tom has been […]
Read More
Commenting on the newly published London Drugs Commission report entitled ‘The Cannabis Conundrum’, CIC CEO Mike Morgan-Giles said: “The Cannabis Industry Council welcomes this report from the London Drugs Commission. “It is beyond doubt that the current system is disproportionately impacting ethnic minority communities and reform is badly needed. “The CIC contributed to the commission’s […]
Read More
In this month’s episode, Luke speaks to Liam O’Dowd, Editor and Co-Founder of leafie. Liam explores leafie’s approach, highlighting how the magazine’s commitment to independent, evidence-based journalism counters the negative cannabis narrative found in some mainstream media outlets. The podcast can be listened to now via Spotify, Amazon, Apple and more.
Read More
The Medicines & Healthcare products Regulatory Agency (MHRA) has stated on its website this month that: “if a company markets a CBD containing product that makes a medicinal claim it will be considered to fall within the definition of a medical product contained in The Human Medicines Regulations 2012…Medicinal products must hold a Marketing Authorisation […]
Read More
In this month’s episode, Luke speaks to Adam Windish, Chief Revenue Officer of the medical division of British Cannabis. Adam explores how his experience as a patient has deepend his understanding of the needs of medicinal cannabis users, along with how British Cannabis has responded to these needs. The podcast can be listened to now […]
Read More
The Government has responded to the Advisory Council on the Misuse of Drugs (ACMD) in respect to THC levels within industrial hemp. The Government say they have accepted ACMD proposals to increase THC levels from 0.2% to 0.3%, noting that “the change is expected to yield economic advantages by providing access to more hemp varieties. […]
Read More